Fondaparinux Sodium News
Fondaparinux Sodium currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Fondaparinux Sodium with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (20):
- pulmonary embolism (disease) (96.4%)
- primary release disorder of platelets (93.1%)
- pseudo-von Willebrand disease (90.9%)
- Glanzmann thrombasthenia (90.6%)
- Ledderhose disease (89.3%)
- vertebral artery occlusion (87.4%)
- retinal microaneurysm (87.4%)
- arteriosclerotic retinopathy (87.4%)
- infantile digital fibromatosis (87.0%)
- palmar fibromatosis (86.5%)
- retinal telangiectasia (86.4%)
- thrombotic thrombocytopenic purpura (86.3%)
- retinal artery occlusion (84.5%)
- penile fibromatosis (84.5%)
- atypical hemolytic-uremic syndrome with thrombomodulin anomaly (80.7%)
- purpura fulminans (78.5%)
- neuropathy, painful (78.0%)
- breast fibrocystic disease (75.6%)
- thrombocytopenic purpura (75.2%)
- hepatopulmonary syndrome (75.0%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.